TiumBio

1 Decision Maker · 1 Verified Contact

📍 Seongnam, Kyonggi-do, South KoreaFinance & Banking🗓 Est. 2016👥 51–100 employees

About TiumBio

TiumBio is a drug developer working on treatments for cancer.

Leadership & Decision Makers

Contact details of 1 TiumBio decision makers

Kim Hun-taek

Founder & CEO

General Emails

General company emails, e.g. customer support lines

    dongwoo@tiumbio.com

    Unclassified inbox

    recruit@tiumbio.com

    Unclassified inbox

    nce401_tu2218@tiumbio.com

    Unclassified inbox

    relationsdayesong@tiumbio.com

    Unclassified inbox

    junseokjang@tiumbio.com

    Unclassified inbox

Similar Companies like TiumBio

Team8

team8.vc
Cybersecurity · Tel Aviv-yafo, Tel Aviv, Israel · Est. 2014 · 101–250 employees

HQ: Tel Aviv-yafo, Tel Aviv, Israel

Sequoia Capital

sequoiacap.com
Finance & Banking · Menlo Park, California, United States · Est. 1972 · 101–250 employees

HQ: Menlo Park, California, United States

Finance & Banking · New York, NY · Est. 2001 · 11–50 employees

HQ: New York, NY

Blackstone Group

blackstone.com
Finance & Banking · New York, NY · Est. 1985 · 251–500 employees

HQ: New York, NY

Finance & Banking · Toronto, Ontario, Canada · Est. 1987 · 251–500 employees

HQ: Toronto, Ontario, Canada

Explore similar firms in the Finance & Banking sector

Company Info

Last updated: 30/07/2025

031-600-1500

Seongnam, Kyonggi-do, South Korea

Employees: 51-100
Founded Date: 2016
Company Type: For Profit
Stock Symbol: KOSDAQ:321550
Operating Status: Active
Last Funding Type: Post-IPO Equity
Phone Number: 031-600-1500
Last Investment Activity: Mar 11, 2024
Investments Activity: Mar 11, 2024 Dec 29, 2023 Dec 29, 2023

Our service is undergoing beta testing, and you can get all the information that is closed on this page for free by registering. You will not need to provide your credit/debit card details.